Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial.
Saved in:
| Title: | Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial. |
|---|---|
| Authors: | Tariot PN; Banner Alzheimer's Institute, Phoenix, AZ, USA. Electronic address: pierre.tariot@bannerhealth.com., Lopera FS; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Ríos-Romenets S; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Sink KM; Genentech, San Francisco, CA, USA., Giraldo-Chica M; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Acosta-Baena N; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Villegas G; University of Antioquia, Medellín, Colombia., Espinosa A; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia; Hospital San Juan de Dios de Yarumal, Antioquia, Colombia., Castaño ML; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Muñoz C; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Ospina P; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Bocanegra Y; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Tirado V; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Henao E; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Cardona E; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Luna E; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Lopez H; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Sánchez G; Cardiomet Cequin, Universidad del Quindío, Armenia, Colombia; San Juan de Dios Hospital, Armenia, Colombia., Collazos MM; Marly's Clinic, Bogotá, Colombia., Alvarez S; Hospital Pablo Tobón Uribe, Medellín, Colombia., Aguillón D; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia., Hu N; Genentech, San Francisco, CA, USA., Clayton D; Genentech, San Francisco, CA, USA., Bittner T; Genentech, San Francisco, CA, USA; F Hoffmann-La Roche, Basel, Switzerland., Schneider A; F Hoffmann-La Roche, Basel, Switzerland., Dolton M; Genentech, San Francisco, CA, USA., Poon V; Genentech, San Francisco, CA, USA., Nguyen J; Genentech, San Francisco, CA, USA., Thomas RG; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, San Diego, CA, USA., Schneider LS; Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA., Chen K; Banner Alzheimer's Institute, Phoenix, AZ, USA., Su Y; Banner Alzheimer's Institute, Phoenix, AZ, USA., Alexander RC; Banner Alzheimer's Institute, Phoenix, AZ, USA., Quiroz YT; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia; Departments of Psychiatry and Neurology, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA, USA., Cai Y; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Xu YR; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ostaszewski B; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Selkoe DJ; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ashton NJ; Banner Alzheimer's Institute, Phoenix, AZ, USA; Banner Sun Health Research Institute, Sun City, AZ, USA; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden., Denkinger MN; Banner Sun Health Research Institute, Sun City, AZ, USA., Jakimovich LJ; Banner Alzheimer's Institute, Phoenix, AZ, USA., Doody RS; Genentech, San Francisco, CA, USA; F Hoffmann-La Roche, Basel, Switzerland., Langbaum JB; Banner Alzheimer's Institute, Phoenix, AZ, USA., Reiman EM; Banner Alzheimer's Institute, Phoenix, AZ, USA. |
| Source: | The Lancet. Neurology [Lancet Neurol] 2026 Feb; Vol. 25 (2), pp. 147-159. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465 (Electronic) Linking ISSN: 14744422 NLM ISO Abbreviation: Lancet Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41579901 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1<superscript>Glu280Ala</superscript> mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tariot+PN%22">Tariot PN</searchLink>; Banner Alzheimer's Institute, Phoenix, AZ, USA. Electronic address: pierre.tariot@bannerhealth.com.<br /><searchLink fieldCode="AU" term="%22Lopera+FS%22">Lopera FS</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Ríos-Romenets+S%22">Ríos-Romenets S</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Sink+KM%22">Sink KM</searchLink>; Genentech, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Giraldo-Chica+M%22">Giraldo-Chica M</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Acosta-Baena+N%22">Acosta-Baena N</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Villegas+G%22">Villegas G</searchLink>; University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Espinosa+A%22">Espinosa A</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia; Hospital San Juan de Dios de Yarumal, Antioquia, Colombia.<br /><searchLink fieldCode="AU" term="%22Castaño+ML%22">Castaño ML</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Muñoz+C%22">Muñoz C</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Ospina+P%22">Ospina P</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Bocanegra+Y%22">Bocanegra Y</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Tirado+V%22">Tirado V</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Henao+E%22">Henao E</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Cardona+E%22">Cardona E</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Luna+E%22">Luna E</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Lopez+H%22">Lopez H</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Sánchez+G%22">Sánchez G</searchLink>; Cardiomet Cequin, Universidad del Quindío, Armenia, Colombia; San Juan de Dios Hospital, Armenia, Colombia.<br /><searchLink fieldCode="AU" term="%22Collazos+MM%22">Collazos MM</searchLink>; Marly's Clinic, Bogotá, Colombia.<br /><searchLink fieldCode="AU" term="%22Alvarez+S%22">Alvarez S</searchLink>; Hospital Pablo Tobón Uribe, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Aguillón+D%22">Aguillón D</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Hu+N%22">Hu N</searchLink>; Genentech, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Clayton+D%22">Clayton D</searchLink>; Genentech, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bittner+T%22">Bittner T</searchLink>; Genentech, San Francisco, CA, USA; F Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schneider+A%22">Schneider A</searchLink>; F Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dolton+M%22">Dolton M</searchLink>; Genentech, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Poon+V%22">Poon V</searchLink>; Genentech, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+J%22">Nguyen J</searchLink>; Genentech, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+RG%22">Thomas RG</searchLink>; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Schneider+LS%22">Schneider LS</searchLink>; Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+K%22">Chen K</searchLink>; Banner Alzheimer's Institute, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Su+Y%22">Su Y</searchLink>; Banner Alzheimer's Institute, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Alexander+RC%22">Alexander RC</searchLink>; Banner Alzheimer's Institute, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Quiroz+YT%22">Quiroz YT</searchLink>; Neuroscience Group of Antioquia (GNA), University of Antioquia, Medellín, Colombia; Departments of Psychiatry and Neurology, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cai+Y%22">Cai Y</searchLink>; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Xu+YR%22">Xu YR</searchLink>; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ostaszewski+B%22">Ostaszewski B</searchLink>; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Selkoe+DJ%22">Selkoe DJ</searchLink>; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ashton+NJ%22">Ashton NJ</searchLink>; Banner Alzheimer's Institute, Phoenix, AZ, USA; Banner Sun Health Research Institute, Sun City, AZ, USA; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.<br /><searchLink fieldCode="AU" term="%22Denkinger+MN%22">Denkinger MN</searchLink>; Banner Sun Health Research Institute, Sun City, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Jakimovich+LJ%22">Jakimovich LJ</searchLink>; Banner Alzheimer's Institute, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Doody+RS%22">Doody RS</searchLink>; Genentech, San Francisco, CA, USA; F Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Langbaum+JB%22">Langbaum JB</searchLink>; Banner Alzheimer's Institute, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Reiman+EM%22">Reiman EM</searchLink>; Banner Alzheimer's Institute, Phoenix, AZ, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101139309%22">The Lancet. Neurology</searchLink> [Lancet Neurol] 2026 Feb; Vol. 25 (2), pp. 147-159. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lancet+Pub%2E+Group%22">Lancet Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101139309 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-4465 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214744422%22">14744422 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Neurol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41579901 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1474-4422(25)00426-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 147 Titles: – TitleFull: Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tariot PN – PersonEntity: Name: NameFull: Lopera FS – PersonEntity: Name: NameFull: Ríos-Romenets S – PersonEntity: Name: NameFull: Sink KM – PersonEntity: Name: NameFull: Giraldo-Chica M – PersonEntity: Name: NameFull: Acosta-Baena N – PersonEntity: Name: NameFull: Villegas G – PersonEntity: Name: NameFull: Espinosa A – PersonEntity: Name: NameFull: Castaño ML – PersonEntity: Name: NameFull: Muñoz C – PersonEntity: Name: NameFull: Ospina P – PersonEntity: Name: NameFull: Bocanegra Y – PersonEntity: Name: NameFull: Tirado V – PersonEntity: Name: NameFull: Henao E – PersonEntity: Name: NameFull: Cardona E – PersonEntity: Name: NameFull: Luna E – PersonEntity: Name: NameFull: Lopez H – PersonEntity: Name: NameFull: Sánchez G – PersonEntity: Name: NameFull: Collazos MM – PersonEntity: Name: NameFull: Alvarez S – PersonEntity: Name: NameFull: Aguillón D – PersonEntity: Name: NameFull: Hu N – PersonEntity: Name: NameFull: Clayton D – PersonEntity: Name: NameFull: Bittner T – PersonEntity: Name: NameFull: Schneider A – PersonEntity: Name: NameFull: Dolton M – PersonEntity: Name: NameFull: Poon V – PersonEntity: Name: NameFull: Nguyen J – PersonEntity: Name: NameFull: Thomas RG – PersonEntity: Name: NameFull: Schneider LS – PersonEntity: Name: NameFull: Chen K – PersonEntity: Name: NameFull: Su Y – PersonEntity: Name: NameFull: Alexander RC – PersonEntity: Name: NameFull: Quiroz YT – PersonEntity: Name: NameFull: Cai Y – PersonEntity: Name: NameFull: Xu YR – PersonEntity: Name: NameFull: Ostaszewski B – PersonEntity: Name: NameFull: Selkoe DJ – PersonEntity: Name: NameFull: Ashton NJ – PersonEntity: Name: NameFull: Denkinger MN – PersonEntity: Name: NameFull: Jakimovich LJ – PersonEntity: Name: NameFull: Doody RS – PersonEntity: Name: NameFull: Langbaum JB – PersonEntity: Name: NameFull: Reiman EM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2026 Feb Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1474-4465 Numbering: – Type: volume Value: 25 – Type: issue Value: 2 Titles: – TitleFull: The Lancet. Neurology Type: main |
| ResultId | 1 |